Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player






 

 

The LUTE clinical research study maybe right for you.

The LUTE study is taking place at different locations around the world; about 2,800 people around the world are expected to take part.

The purpose of the study is to learn whether the investigational study medication could be beneficial for adults with asthma who do not have good control of their symptoms despite being on an inhaled corticosteroid plus a second asthma medication. The LUTE study will help doctors learn if using the investigational medication to block IL-13 may help reduce asthma attacks and improve lung function in patients with severe uncontrolled asthma. This study could benefit other people who have a similar medical condition in the future.

How long will the study last?

The first part of the study lasts for one year. Participants will have a few visits during the first month, with monthly visits after that. At the end of the first year, participants may be eligible to continue in the study.

What will happen during the study?

All participants will visit the study clinic to receive the study medication and for health assessments, including study-related:

  • Physical exams
  • Vital sign measurements
  • Lung function tests
  • ECG's (simple, painless tests that record the heart's electrical activity)
  • Blood and urine tests

At some study visits, participants will also be asked to complete questionnaires about their asthma symptoms and quality of life.

Participants will be given a device to take home and use in between visits. The device has a peak expiratory flow (PEF) meter with a built-in electronic diary. Participants will have to complete the e-diary once a day and bring the device with them to each study visit.

Who can participate?

You may be eligible to participate in the LUTE study if you:

  • Are 18 to 75 years of age
  • Have been diagnosed with severe asthma for at least one year
  • Are on an inhaled corticosteroid
  • Have been on a second asthma controller medication for at least six months

There are other eligibility criteria that may or may not make you eligible to participate in these studies. The study doctor will review these criteria with you.

Find out if you may be eligible to participant. Call (785) 368-0742 or email cmosher@stormontvail.org.